A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 4347-4355

  Petersen, Frank ^a,b   Bock, Lothar ^b   Flad, Hans Dieter ^b   Brandt, Ernst ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; INTERLEUKIN 8 RECEPTOR; PROTEOGLYCAN; THROMBOCYTE FACTOR 4;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL SPECIFICITY; CROSS LINKING; ENZYME ACTIVITY; EXOCYTOSIS; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RECEPTOR BINDING;

CELLS, CULTURED; CHONDROITIN SULFATES; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET FACTOR 4; PROTEOGLYCANS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 0032532630     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Oppenheim, J. J., C. O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
2. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.
3. Petersen, F., H.-D. Flad, and E. Brandt. 1994. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways: discrepancies in binding affinities, receptor densities, and biologic effects. J. Immunol. 152:2467.
4. Schumacher, C., I. Clark-Lewis, M. Baggiolini, and B. Moser. 1992. High- and low-affinity binding of GROα and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. USA 89:10542.
5. Holmes, W. E., J. Lee, W. J. Kuang, G. C. Rice, and W. J. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278.
6. Murphy, P. M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280.
7. Clark-Lewis, I., B. Dewald, T. Geiser, B. Moser, and M. Baggiolini. 1993. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA 90:3574.
8. Moser, B., B. Dewald, L. Barella, C. Schumacher, M. Baggiolini, and I. Clark-Lewis. 1993. Interleukin-8 antagonists generated by N-terminal modification. J. Biol. Chem. 268:7125.
9. Schraufstätter, I. U., D. S. Barritt, M. Ma, Z. G. Oades, and C. G. Cochrane. 1993. Multiple sites on IL-8 responsible for binding to α and β IL-8 receptors. J. Immunol. 151:6418.
10. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. [Gamma]-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672.
11. Niewiarowski, S., B. Rucinski, and A. Z. Budzynski. 1979. Low affinity platelet factor 4 and high affinity platelet factor 4: two antiheparin factors secreted by human platelets. Thromb. Haemost. 42:1679.
12. Files, J. C., T. W. Malpass, E. K. Yee, J. L. Ritchie, and L. A. Harker. 1981. Studies of human platelet α-release in vivo. Blood 58:607.
13. Skerka, C., S. G. Irving, A. Bialonski, and P. F. Zipfel. 1993. Cell type specific expression of members of the IL-8/NAP-1 gene family. Cytokine 5:112.
14. Ohmori, Y., and T. A. Hamilton. 1994. Cell type and stimulus specific regulation of chemokine gene expression. Biochem. Biophys. Res. Commun. 198:590.
15. McLaren, K. M., I. Holloway, and D. S. Pepper. 1982. Human platelet factor 4 and tissue mast cells. Thromb. Res. 19:293.
16. Petersen, F., A. Ludwig, H. D. Flad, and E. Brandt. 1996. TNF-α renders human neutrophils responsive to platelet factor 4: comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J. Immunol. 156:1954.
17. Bischoff, S. C., M. Krieger, T. Brunner, A. Rot, V. von Tscharner, M. Baggiolini, and C. A. Dahinden. 1993. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur. J. Immunol. 23:761.
18. Elsner, J., V. Kaever, A. Emmendorffer, T. Breidenbach, M. L. Lohmann Matthes, and J. Roesler. 1992. Heterogeneity in the mobilization of cytoplasmic calcium by human polymorphonuclear leukocytes in response to fMLP, C5a and IL-8/NAP-1. J. Leukocyte Biol. 51:77.
19. Lee, J., R. Horuk, G. C. Rice, G. L. Bennett, T. Camerato, and W. I. Wood. 1992. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 267:16283.
20. Neote, K., D. DiGregorio, J. Y. Mak, R. Horuk, and T. J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415.
21. i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. J. Leukocyte Biol. 50: 279.
22. Deuel, T. F., R. M. Senior, D. Chang, G. L. Griffin, R. L. Heinrikson, and E. T. Kaiser. 1981. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. USA 78:4584.
23. Leonard, E. J., T. Yoshimura, A. Rot, K. Noer, A. Walz, M. Baggiolini, D. A. Walz, E. J. Goetzl, and C. W. Castor. 1991. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J. Leukocyte Biol. 49:258.
24. Goldman, D. W., A. L. Hannah, and E. J. Goetzl. 1985. Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70). Immunology 54:163.
25. Bebawy, S. T., J. Gorka, T. M. Hyers, and R. O. Webster. 1986. In vitro effects of platelet factor 4 on normal human neutrophil functions. J. Leukocyte Biol. 39:423.
26. Walz, A., B. Dewald, V. von Tscharner, and M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J. Exp. Med. 170:1745.
27. Yan, Z., J. Zhang, J. C. Holt, G. J. Stewart, S. Niewiarowski, and M. Poncz. 1994. Structural requirements of platelet chemokines for neutrophil activation. Blood 84:2329.
28. Detmers, P. A., D. E. Powell, A. Walz, I. Clark-Lewis, M. Baggiolini, and Z. A. Cohn. 1991. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J. Immunol. 147:4211.
29. Busch, C., J. Dawes, D. S. Pepper, and A. Wasteson. 1980. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb. Res. 19:129.
30. Rybak, M. E., M. A. Gimbrone, P. F. Davies, and R. I. Handin. 1989. Interaction of platelet factor four with cultured vascular endothelial cells. Blood 73:1534.
31. Watson, J. B., S. B. Getzler, and D. F. Mosher. 1994. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J. Clin. Invest. 94:261.
32. Luster, A. D., S. M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:219.
33. Brandt, E., F. Petersen, and H.-D. Flad. 1992. Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J. Immunol. 149:1356.
34. Brandt, E., J. Van Damme, and H.-D. Flad. 1991. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3:311.
35. Munson, P. J., and D. Rodbard. 1980. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220.
36. Mayo, K. H., and S. Barker. 1992. Molten globule monomer to condensed dimer: role of disulfide bonds in platelet factor-4 and subunit association. Biochemistry 31:12255.
37. 1H NMR spectroscopy. Biochemistry 28:9469.
38. Miettinen, H. M., S. N. Edwards, and M. Jalkanen. 1994. Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol. Biol. Cell 5:1325.
39. Nackaerts, K., E. Verbeken, G. Deneffe, B. Vanderschueren, M. Demedts, and G. David. 1997. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int. J. Cancer 74:335.
40. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, H. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385.
41. Rot, A., E. Hub, J. Middleton, F. Pons, C. Rabeck, K. Thierer, J. Wintle, B. Wolff, M. Zsak, and P. Dukor. 1996. Some aspects of IL-8 pathophysiology. III. Chemokine interaction with endothelial cells. J. Leukocyte Biol. 59:39.
42. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13:291.
43. Cassatella, M. A., S. Gasperini, F. Calzetti, A. Bertagnin, A. D. Luster, and P. P. McDonald. 1997. Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27:111.
44. Witt, D. P., and A. D. Lander. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:394.
45. Webb, L. M. C., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90:7158.
46. Clore, G. M., E. Appella, M. Yamada, K. Matsushima, and A. M. Gronenborn. 1990. Three-dimensional structure of interleukin 8 in solution. Biochemistry 29: 1689.
47. 1H-nuclear magnetic resonance spectroscopy. Biochem. J. 304:371.
48. 1H NMR spectroscopy. J. Biol. Chem. 269:32909.
49. Lodi, P. J., D. S. Garrett, J. Kuszewski, M. L.-S. Tsang, J. A. Weatherbee, W. J. Leonard, A. M. Gronenborn, and G. M. Clore. 1994. High-resolution solution structure of the β chemokine hMIP-1β by multidimensional NMR. Science 263:1762.
50. Rajarathnam, K., B. D. Sykes, C. M. Kay, B. Dewald, T. Geiser, M. Baggiolini, and I. Clark-Lewis. 1994. Neutrophil activation by monomeric interleukin-8. Science 264:90.
51. Hoogewerf, A. J., G. S. V. Kuschert, A. E. I. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. C. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570.
52. Stringer, S. E., and J. T. Gallagher. 1997. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 272:20508.
53. Levine, S. P., and L. S. Krentz. 1977. Development of a radioimmunoassay for human platelet factor 4. Thromb. Res. 11:673.
54. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841.